Integer
Develops and manufactures cardiac, vascular, and neuromodulation devices for medical-technology companies.
$125.33
After-hours close+0.01 (+0.01%)
At close$125.32(+0.02%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 132.22%Insiders 1.05%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 33.95M · Float 33.52M · 98.7% free float
Institutions13F, as of Jun 30, 2026
335 holders · 44.89M shares · 50 new positions · 150 increased · 130 reduced · 42 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.35M | 15.77% | +47.9K | Aug 7, 2026 |
| Invesco Ltd. | 2.25M | 6.62% | +277.9K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 2.04M | 6.01% | −6.5K | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 1.63M | 4.79% | +143.4K | Aug 11, 2026 |
| Nomura Holdings Inc | 1.55M | 4.58% | +1.11M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.53M | 4.51% | −5.4K | Aug 13, 2026 |
| State Street Corp | 1.41M | 4.16% | +14.9K | Aug 7, 2026 |
| Morgan Stanley | 1.35M | 3.96% | −193.5K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.70% | 5.13M | 13G | Jul 17, 2025 ↗ |
| Vanguard Portfolio Management | 6.03% | 2.08M | 13G | Apr 29, 2026 ↗ |
| Invesco Ltd. | 5.70% | 1.97M | 13G | May 6, 2026 ↗ |
| Nomura Holdings Inc | 5.40% | 1.82M | 13G | Aug 14, 2026 ↗ |
| Vanguard Capital Management | 5.25% | 1.81M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Pamela G. Bailey | director | 54.3K | 0.16% | Jan 5, 2026 |
| Payman Khales | director, officer: President & CEO | 51.8K | 0.15% | Feb 24, 2026 |
| Joseph W. Dziedzic | director, officer: President & CEO | 45.8K | 0.13% | Jun 13, 2025 |
| Kirk K. Thor | officer: Chief Human Resources Officer | 38.7K | 0.11% | Jul 1, 2026 |
| Filippo Passerini | director | 31.1K | 0.09% | May 22, 2026 |
| Martin C. Maxwell | director | 25.1K | 0.07% | May 22, 2026 |
| Donald J. Spence | director | 18.8K | 0.06% | Jun 6, 2025 |
| Andrew Senn | officer: President, Cardio & Vascular | 13.9K | 0.04% | Feb 24, 2026 |
| Cheryl C. Capps | director | 13.7K | 0.04% | May 22, 2026 |
| Diron Smith | officer: EVP, Chief Financial Officer | 12.9K | 0.04% | May 12, 2026 |
49 people have not refiled in the last 18 months (1.44M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 13, 2026 | Tommy P. Thomasofficer: VP, Corporate Controller | Sale | 825 | $85.00 | 4,381 |
| Nov 11, 2025 | Tommy P. Thomasofficer: VP, Corporate Controller | Sale | 884 | $70.15 | 3,596 |
| Nov 12, 2025 | John A. Harrisofficer: EVP, Global Ops and Manufactur | Purchase | 1,650 | $70.00 | 6,066 |
| Nov 6, 2025 | Cheryl C. Cappsdirector | Purchase | 1,600 | $66.70 | 11,702 |
| Nov 7, 2025 | Diron Smithofficer: EVP, Chief Financial Officer | Purchase | 1,116 | $67.19 | 7,698 |
| Oct 30, 2025 | Payman Khalesdirector, officer: President & CEO | Purchase | 3,127 | $64.94 | 22,865 |
CongressHouse and Senate disclosures
Not reported.